Nine-Year Follow-Up of Children with Atopic Dermatitis by General Practitioners

Miséry, Laurent; Ansolabehere, X.; Grandfils, N.; Georgescu, Victor; Taïeb, C.

doi:10.1159/000358296

Cited by 11 publications

(9 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our findings are in agreement with the French study of children with atopic eczema 5 and the Canadian, German, and American studies of children with asthma 6 – 8 described in the “Introduction” section, and extend their findings by describing total health service use, but also more detailed subtypes of health services, medications, and costs. Furthermore, our results confirm other studies showing that far from all children with atopic disease get specialized treatment, even though it is recommended.…”

Section: Discussionsupporting

confidence: 91%

“…A French study found increased use of prescribed medication and higher costs of general practitioner consultations and prescribed medication among children with atopic eczema compared with healthy controls. 5 A Canadian and a German study found increased likelihood of consultations with the general practitioner and of hospitalization among children with asthma compared with children without. 6 , 7 Finally, an American study of children with the same insurance found increased odds of using prescribed medication, outpatient hospital visits, emergency department visits, and hospitalization among children with asthma compared with children without.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Health service use among children with and without eczema, asthma, and hay fever

Hammer-Helmich¹,

Linneberg²,

Thomsen³

et al. 2016

CLEP

View full text Add to dashboard Cite

BackgroundAtopic diseases, for example, eczema, asthma, and hay fever, are among the most common chronic diseases of childhood. Knowledge on health service use among children with atopic disease is limited. This study aimed to investigate the total use and costs of health services for children with and without eczema, asthma, and hay fever in a Danish general population.MethodsWe conducted a health survey with four complete birth cohorts from the City of Copenhagen. Individual questionnaire data on eczema, asthma, and hay fever for children aged 3, 6, 11, and 15 years were linked to register information on use and costs of health services and prescribed medication and parental education. In total 9,720 children participated (50.5%).ResultsWe found increased health service use (number of additional consultations per year [95% confidence interval]) among children with current eczema symptoms (1.77 [1.29–2.26]), current asthma symptoms (2.53 [2.08–2.98]), and current hay fever symptoms (1.21 [0.74–1.67]), compared with children without these symptoms. We also found increased use of prescribed medication and most subtypes of health services. Current asthma symptoms and current eczema symptoms, but not current hay fever symptoms, increased the health service costs with at least €300 per year per child.ConclusionChildren with eczema, asthma, and hay fever used health services and prescribed medication more than children without these diseases.

show abstract

Section: Discussionsupporting

confidence: 91%

Section: Introductionmentioning

confidence: 99%

Health service use among children with and without eczema, asthma, and hay fever

Hammer-Helmich¹,

Linneberg²,

Thomsen³

et al. 2016

CLEP

View full text Add to dashboard Cite

show abstract

“…The rate of comorbidities (including ophthalmic complications) is reported to be significantly higher in infants with AD than in the control group (47% vs. 28%) [61]. Other sources estimate the frequency of ocular complications in AD to be approximately 16.7% [62].…”

Section: Childrenmentioning

confidence: 99%

Ophthalmic manifestations of atopic dermatitis

Pietruszyńska¹,

Zawadzka-Krajewska²,

Duda³

et al. 2020

pdia

View full text Add to dashboard Cite

Atopic dermatitis is a chronic condition of complex etiology, whose clinical course involves remission and recurrence. It is not an isolated disease entity affecting only the skin, but one that co-occurs with disorders of other organs. Numerous literature reports have long confirmed the relationship between the disorder and a growing number of ophthalmic manifestations such as keratoconus and retinal detachment. Further studies are required to establish the cause of correlations and to allow for implementation of appropriate prophylaxis and treatment. The aim of the present paper is to review published literature regarding the correlation between atopic dermatitis and ophthalmic manifestations in adults and children.

show abstract

“…A total of 26 studies (33%) were considered to have conducted a form of cost‐of‐illness study, one of which used a model developed in Excel (Microsoft, Redmond, WA, U.S.A.) . Most of these studies evaluated the cost of eczema within children, with only two papers stating explicitly that they were evaluating adults with eczema . Other papers did not specify the population age, with 11 stating a population of patients with eczema .…”

Section: Resultsmentioning

confidence: 99%

Understanding economic evidence for the prevention and treatment of atopic eczema

2019

View full text Add to dashboard Cite

Summary Background Atopic eczema is an inflammatory skin condition, with a similar impact on health‐related quality of life as other chronic diseases. Increasing pressures on resources within the National Health Service increase the importance of having good economic evidence to inform their allocation. Objectives To educate dermatologists about economic methods with reference to currently available economic evidence on eczema. Methods The role of different types of economic evidence is illustrated by evidence found in a systematic literature search conducted across 12 online databases up to 22 May 2017. Primary empirical studies either reporting the results of a cost‐of‐illness study or evaluating the cost, utility or full economic evaluation of interventions for preventing or treating eczema were included. Two reviewers independently assessed studies for eligibility and performed data abstraction, with disagreements resolved by a third reviewer. Evidence tables of results were produced for narrative discussion. The reporting quality of economic evaluations was assessed. Results Seventy‐eight studies (described in 80 papers) were deemed eligible. Thirty‐three (42%) were judged to be economic evaluations, 12 (15%) cost analyses, six (8%) utility analyses, 26 (33%) cost‐of‐illness studies and one a feasibility study (1%). The calcineurin inhibitors tacrolimus and pimecrolimus, as well as barrier creams, had the most economic evidence available. Partially hydrolysed infant formula was the most commonly evaluated prevention. Conclusions The current level of economic evidence for interventions aimed at preventing and treating eczema is limited compared with that available for clinical outcomes, suggesting that greater collaboration between clinicians and economists might be beneficial.

show abstract

Nine-Year Follow-Up of Children with Atopic Dermatitis by General Practitioners

Cited by 11 publications

References 25 publications

Health service use among children with and without eczema, asthma, and hay fever

Health service use among children with and without eczema, asthma, and hay fever

Ophthalmic manifestations of atopic dermatitis

Understanding economic evidence for the prevention and treatment of atopic eczema

Contact Info

Product

Resources

About